Mylan NV (MYL) Ordinary Shares EUR0.01
Share news, reports & tips
29 July 2019 15:22
(Sharecast News) - Generic pharmaceuticals maker Mylan shares shot up at the bell after posting a second-quarter revenue beat and agreeing to merge with Pfizer's off-patent unit.
9 May 2018 13:11
(Sharecast News) - American speciality pharmaceuticals company Mylan reported a fall in revenue for first-quarter on Wednesday but upped its full year guidance.
4 October 2017 14:56
(ShareCast News) - US-based generic and speciality pharmaceuticals company Mylan announced on Tuesday that the US Food and Drug Administration (FDA) had approved two doses of its generic equivalent to...
25 September 2017 07:57
(ShareCast News) - Indivior has struck an out-of-court settlement to resolve litigation over its Suboxone opiate addiction treatment with Mylan Pharmaceuticals.
5 May 2017 08:13
(ShareCast News) - The US House of Representatives narrowly voted through a range of healthcare reforms in Washington on Thursday, with President Donald Trump claiming that the affordable care act of...
18 January 2017 11:23
(ShareCast News) - The CEO of Pfizer, one of the largest pharmaceutical firms in the United States, has said that the best way to make drug prices in the country more competitive is by initially increasing...
12 January 2017 12:54
(ShareCast News) - CVS Health announced on Thursday that it would be introducing a new generic version of the Epipen, the allergic reaction treatment which has seen prices skyrocket to $600 this year.
16 December 2016 14:55
(ShareCast News) - Twenty states in the United States have filed lawsuits against a number of pharmaceutical companies over accusations of price fixing in the industry.
10 October 2016 12:45
(ShareCast News) - Mylan shares surged in pre-market trade after the company said at the end of last week that it had agreed the terms of a $465m settlement with the US Department of Justice and other...
22 September 2016 10:33
(ShareCast News) - Heather Bresch, chief executive officer of US pharmaceutical firm Mylan, has appeared before a congressional committee in defence of the company's pricing of its Epipen allergy...
21 September 2016 15:05
(ShareCast News) - Novum Pharma has been criticised for bumping up the price of one of its skin creams by over 128%, in the latest instance of so-called "gouging" in the US healthcare market.
Company announcements Announcements
No company announcements about Mylan NV Ordinary Shares EUR0.01 were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2019. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.